(VIANEWS) – Federal Realty Investment Trust (FRT), Whitestone REIT (WSR), Gilead Sciences (GILD) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Federal Realty Investment Trust (FRT)
91.12% Payout Ratio
Federal Realty is a recognized leader in the ownership, operation and redevelopment of high-quality retail-based properties located primarily in major coastal markets from Washington, D.C. to Boston as well as San Francisco and Los Angeles. Founded in 1962, Federal Realty's mission is to deliver long-term, sustainable growth through investing in communities where retail demand exceeds supply. Its expertise includes creating urban, mixed-use neighborhoods like Santana Row in San Jose, California, Pike & Rose in North Bethesda, Maryland and Assembly Row in Somerville, Massachusetts. These unique and vibrant environments that combine shopping, dining, living and working provide a destination experience valued by their respective communities. Federal Realty's 106 properties include approximately 3,100 tenants, in 25 million square feet, and approximately 3,200 residential units. Federal Realty has increased its quarterly dividends to its shareholders for 54 consecutive years, the longest record in the REIT industry. Federal Realty is an S&P 500 index member and its shares are traded on the NYSE under the symbol FRT. For additional information about Federal Realty and its properties, visit www.federalrealty.com.
Earnings Per Share
As for profitability, Federal Realty Investment Trust has a trailing twelve months EPS of $4.67.
PE Ratio
Federal Realty Investment Trust has a trailing twelve months price to earnings ratio of 19.29. Meaning, the purchaser of the share is investing $19.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.05%.
2. Whitestone REIT (WSR)
73.85% Payout Ratio
Whitestone is a community-centered shopping center REIT that acquires, owns, manages, develops and redevelops high-quality open-air neighborhood centers primarily in the largest, fastest-growing and most affluent markets in the Sunbelt. Whitestone seeks to create communities that thrive through creating local connections between consumers in the surrounding communities and a well-crafted mix of national, regional and local tenants that provide daily necessities, needed services, entertainment and experiences. Whitestone is a monthly dividend paying stock and has consistently paid dividends for over 15 years. Whitestone's strong, balanced and managed capital structure provides stability and flexibility for growth and positions Whitestone to perform well through economic cycles.
Earnings Per Share
As for profitability, Whitestone REIT has a trailing twelve months EPS of $0.65.
PE Ratio
Whitestone REIT has a trailing twelve months price to earnings ratio of 14.75. Meaning, the purchaser of the share is investing $14.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.9%.
3. Gilead Sciences (GILD)
66.52% Payout Ratio
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Earnings Per Share
As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.44.
PE Ratio
Gilead Sciences has a trailing twelve months price to earnings ratio of 16.78. Meaning, the purchaser of the share is investing $16.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.11%.
Moving Average
Gilead Sciences’s value is below its 50-day moving average of $78.17 and below its 200-day moving average of $79.71.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 27.04B for the twelve trailing months.
Yearly Top and Bottom Value
Gilead Sciences’s stock is valued at $74.50 at 14:23 EST, way below its 52-week high of $89.74 and way above its 52-week low of $59.27.
4. Banco Bradesco (BBDO)
53.98% Payout Ratio
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil.
Earnings Per Share
As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.34.
PE Ratio
Banco Bradesco has a trailing twelve months price to earnings ratio of 8.79. Meaning, the purchaser of the share is investing $8.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.73%.
Moving Average
Banco Bradesco’s value is above its 50-day moving average of $2.77 and way above its 200-day moving average of $2.63.
Yearly Top and Bottom Value
Banco Bradesco’s stock is valued at $2.99 at 14:23 EST, way under its 52-week high of $3.35 and way higher than its 52-week low of $2.12.
